Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Brand Name :
Synonyms :
Class :
may have an increased hypotensive effect when combined with arsenic trioxide
may have an increased nephrotoxic effect when combined with colistimethate
may have a decrease in excretion rate when combined with tetradecyl sulfuric acid
may have an increased nephrotoxic effect when combined with colistimethate
may have an increased risk of rhabdomyolysis & myoglobinuria when combined with amphotericin b
may have an increased nephrotoxic effect when combined with amphotericin B
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased adverse effect when combined with cardiac glycosides
may have an increased adverse effect when combined with cardiac glycosides
may have an increased adverse effect when combined with cardiac glycosides
may have an increased hypokalemic effect when combined with amphotericin B
may have an increased hypokalemic effect when combined with amphotericin B
may have an increased hypokalemic effect when combined with amphotericin B
may have an increased hypokalemic effect when combined with amphotericin B
may have an increased hypokalemic effect when combined with amphotericin B
may have an increased nephrotoxic effect when combined with cyclosporine
may have an increased hypokalemic effect when combined with dichlorphenamide
may have an increased adverse effect when combined with flucytosine
triamcinolone acetonide/nystatin
may decrease the therapeutic effect when combined with amphotericin b
may decrease the therapeutic effect when combined with amphotericin b
methenamine/sodium salicylate/benzoic acid
may decrease the therapeutic effect when combined with amphotericin b
may decrease the therapeutic effect when combined with amphotericin b
may decrease the therapeutic effect when combined with amphotericin b
may have an increased hypokalemic effect when combined with amphotericin b
may have an increased hypokalemic effect when combined with amphotericin b
may have an increased hypokalemic effect when combined with amphotericin b
may have an increased hypokalemic effect when combined with amphotericin b
may have an increased hypokalemic effect when combined with amphotericin b
When loracarbef is used together with amphotericin B, the risk or seriousness of nephrotoxicity is enhanced
When amphotericin B is used together with capsaicin, this leads to enhanced risk or seriousness of methemoglobinemia
When amphotericin B is used together with droxicam, this leads to enhanced risk or seriousness of nephrotoxicity
when ciprofibrate is given along with acenocoumarol, there is an increased risk of bleeding
amphotericin b leads to a reduction in the rate of excretion of eucalyptus oil which leads to increased level of serum
amphotericin b leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
amphotericin b leads to a reduction in the rate of excretion of pentaerythritol tetranitrate, which leads to an increased level of serum
amphotericin b leads to a reduction in the rate of excretion of potassium acetate, which leads to an increased level of serum
amphotericin b leads to a reduction in the rate of excretion of potassium perchlorate, which leads to an increased level of serum
When lopinavir is used together with amphotericin b, this leads to enhanced risk or seriousness of nephrotoxicity
aminoglycosides' nephrotoxic effect may be intensified by amphotericin B
neomycin/polymyxin B/bacitracin topical
aminoglycosides' nephrotoxic effect may be intensified by amphotericin B
may have an increased hypokalemic effect when combined with amphotericin B
amphotericin b may decrease the excretion rate of almasilate, leading to higher serum levels
Possibility of increase in renal toxicity if given with mechlorethamine
May increase the nephrotoxic effects of aminoglycoside antibiotics
May increase the nephrotoxic effects of aminoglycoside antibiotics
may increase the nephrotoxic effect
may increase the nephrotoxic effect when combined with amphotericin b
may increase the nephrotoxic effect when combined with amphotericin b
may enhance the serum concentration when combined with amphotericin B
the risk of nephrotoxicity may be increased
the risk of methemoglobinemia may be increased
amphotericin b might lead to a reduction in the rate of excretion of telavancin, potentially leading to elevated levels of serum